Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET)
IRVINE, Calif.--(BUSINESS WIRE)--Oct. 17, 2017--
Masimo (NASDAQ: MASI) announced today that it will release financial
results for the third quarter ended September 30, 2017, after the market
closes on Tuesday, October 31, 2017. The conference call to review the
results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by
Joe Kiani, Chairman and Chief Executive Officer, and Micah Young,
Executive Vice President and Chief Financial Officer, along with Mark de
Raad, the company’s retiring CFO.
A live webcast of the conference call will be available online from the
investor relations page of the company's corporate website at www.masimo.com.
The dial-in numbers are (888) 520-7182 for domestic callers and +1 (706)
758-3929 for international callers. The reservation code for both
dial-in numbers is 1906046. After the live webcast, the call will be
available on Masimo's website through November 28, 2017. In addition, a
telephonic replay of the call will be available through November 14,
2017. The replay dial-in numbers are (855) 859-2056 for domestic callers
and +1 (404) 537-3406 for international callers. Please use reservation
code 1906046.
About Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive
monitoring technologies. Our mission is to improve patient outcomes and
reduce the cost of care by taking noninvasive monitoring to new sites
and applications. In 1995, the company debuted Masimo SET®
Measure-through Motion and Low Perfusion™ pulse oximetry, which has been
shown in multiple studies to significantly reduce false alarms and
accurately monitor for true alarms. Masimo SET® is estimated to be used
on more than 100 million patients in leading hospitals and other
healthcare settings around the world. In 2005, Masimo introduced
rainbow® Pulse CO-Oximetry technology, allowing noninvasive and
continuous monitoring of blood constituents that previously could only
be measured invasively, including total hemoglobin (SpHb®), oxygen
content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and
more recently, Pleth Variability Index (PVI®) and Oxygen Reserve Index
(ORI™), in addition to SpO2, pulse rate, and perfusion index (PI). In
2014, Masimo introduced Root®, an intuitive patient monitoring and
connectivity platform with the Masimo Open Connect (MOC-9™) interface.
Masimo is also taking an active leadership role in mHealth with products
such as the Radius-7™ wearable patient monitor and the MightySat™
fingertip pulse oximeter. Additional information about Masimo and its
products may be found at www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome
and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites
and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are trademarks
or registered trademarks of Masimo.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171017005585/en/
Source: Masimo
Masimo
Investor Contact:
Eli Kammerman, (949) 297-7077
[email protected]
or
Media
Contact:
Irene Paigah, (858) 859-7001
[email protected]